A Study to Evaluate the Safety and Tolerability of ILB-202

NCT05843799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ILB-202
DRUG: Placebo

Sponsor

ILIAS Biologics Inc.